)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
MatsukiyoCocokara & Co
MatsukiyoCocokara & Co (3088) investor relations material
MatsukiyoCocokara & Co Q1 2027 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q1 2027 earnings summary10 Aug, 2026
Executive summary
Net sales rose 5.7% year-over-year to ¥289,348 million for the quarter ended June 30, 2026, with operating profit up 8.5% to ¥21,487 million and profit attributable to owners of parent up 14.9% to ¥14,865 million.
The company advanced its differentiation, investment, and sustainability strategies, including expanding its store network, investing in digital and operational infrastructure, and enhancing private brand offerings.
Two new subsidiaries, UNIVERSAL DRUG CO., LTD. and AppBrew Inc., were added to the consolidation scope, supporting growth and platform expansion.
Financial highlights
EBITDA increased 8.9% year-over-year to ¥27,662 million; ordinary profit rose 8.8% to ¥22,822 million.
Gross profit improved to ¥103,375 million from ¥94,283 million year-over-year.
Basic earnings per share increased to ¥37.59 from ¥32.30 year-over-year.
Comprehensive income grew 14.3% to ¥14,345 million.
Outlook and guidance
Full-year net sales forecast at ¥1,155,000 million (up 3.4% year-over-year), with profit attributable to owners of parent projected at ¥59,000 million (up 5.8%).
No revisions to previously announced earnings or dividend forecasts.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from MatsukiyoCocokara & Co
- Record sales and profit growth achieved, with further expansion forecast on strong cosmetics and M&A.3088
Q4 2026 - Sales and profits rose on strong cosmetics and M&A, with stable margins and a higher dividend.3088Q3 2026
- Record sales and profits, robust PB and cosmetics growth, and higher shareholder returns.3088Q2 2026
- Record-high sales and profits driven by cosmetics and digital growth, with stable outlook.3088Q1 2026
- Net sales rose 3.5% YoY, but net profit declined amid share buybacks and weather losses.3088Q2 2025
- Sales rose 4.6% year-over-year, but profit declined due to higher SG&A expenses.3088Q1 2025
- Profits and sales climbed on cosmetics and digital growth, with further gains expected.3088Q4 2025
- Sales and profit rose, but net income dipped amid investment and industry competition.3088Q3 2025
Next MatsukiyoCocokara & Co earnings date
Q2 202713 Nov, 2026
MatsukiyoCocokara & Co
Next MatsukiyoCocokara & Co earnings date
Q2 202713 Nov, 2026
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
MatsukiyoCocokara & Co is a Japan-based company operating a nationwide network of drugstores and pharmacies. Formed through the merger of Matsumotokiyoshi Holdings and Cocokara Fine Inc., the company offers pharmaceuticals, cosmetics, health foods, daily necessities, and personal care products. It serves customers through physical retail locations and online platforms, with a focus on both prescription and over-the-counter products. MatsukiyoCocokara & Co also engages in private brand development and operates dispensing pharmacies. The company is headquartered in Tokyo, Japan, and its shares are listed on the TSE.